News Search News Filter by: Industry Team AutomotiveEmerging TechnologiesEnergyFood & Beverage Health CareHospitality, Resort & GolfInsurance & ReinsuranceLife Sciences Medical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryFreight & Commuter RailGovernment Procurement Immigration, Nationality & Consular LawNHTSA & Motor Vehicle SafetyPolitical LawPublic Policy Intellectual Property All Intellectual PropertyChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChina JapanLatin America Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & Litigation Office BostonChicagoDetroitJacksonvilleLos AngelesMadisonMiami MilwaukeeNew YorkOrlandoSacramentoSan DiegoSan Diego/Del MarSan Francisco ShanghaiSilicon ValleyTallahasseeTampaTokyoWashington, D.C. Topic Foreign Corrupt Practices Act (FCPA) Featured View All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared Media Contact Linda Yun Senior Public Relations Manager lyun foley.com 312.832.4755 In the News Press Releases Rosen Appeared on Chain of Command 22 July 2012 –BioCentury TV Partner David Rosen appeared on BioCentury TV on July 22, 2012 to speak on a program titled "Chain of Command." Click here to view the complete program. Jul 22 Rosen Quoted on FDA Guidance 12 October 2011 –Genetic Engineering & Biotechnology News Foley Partner David Rosen was quoted in an article that appeared in Genetic Engineering & Biotechnology News on October 12, 2011 titled "Extent of Feedback on RUO/IUO... Oct 12 Rosen Quoted on Generic Drug Guidelines 27 October 2011 –Bloomberg News Foley Partner David Rosen was quoted in an article that appeared in Bloomberg News on October 27, 2011 titled "FDA tightens standards to prove generics can be swapped."... Oct 27 Rosen Quoted in Law360 10 May 2013 –Law360 Partner David L. Rosen was quoted in a May 10, 2013 Law360 article titled, “Drug Cos. See Path to Legal Off-Label Marketing.” The piece discusses the drug industry’s... May 10 Rosen Quoted on Product Safety Evaluation 11 January 2012 –USA Today Foley Partner David Rosen discusses product safety evaluation following the Food and Drug Administration's (FDA) warning of fines and sanctions to Johnson &... Jan 11 Key on GlaxoSmithKline Petition 11 August 2008 –National Law Journal Foley attorney Sarah Key authored an article titled “Glaxo’s big, fat attack on dietary supplements” in the August 11, 2008 issue of the National Law Journal. The... Aug 11 Rosen Quoted on Johnson & Johnson 23 July 2010 –CNN Money Foley Partner David Rosen was quoted in an article that appeared in CNN Money on July 23, 2010 titled “Pepcid factory problems mirror Tylenol mess.” Rosen discusses... Jul 23 Rosen Quoted on Foreign Clinical Trials 24 June 2010 –FDA Week Foley Partner David Rosen was quoted in an article that appeared in FDA Week on June 24, 2010 titled “OIG, Stakeholders Urge FDA To Clamp Down On Foreign Clinical... Jun 24 Rosen Quoted on FDA Compliance Regulations 24 August 2010 –CNNMoney Foley Partner David Rosen was quoted in an article that appeared in CNNMoney on August 24, 2010 titled "Recall fallout: FDA puts execs on notice." Rosen discusses... Aug 24 Related 1 2 3
Rosen Appeared on Chain of Command 22 July 2012 –BioCentury TV Partner David Rosen appeared on BioCentury TV on July 22, 2012 to speak on a program titled "Chain of Command." Click here to view the complete program. Jul 22
Rosen Quoted on FDA Guidance 12 October 2011 –Genetic Engineering & Biotechnology News Foley Partner David Rosen was quoted in an article that appeared in Genetic Engineering & Biotechnology News on October 12, 2011 titled "Extent of Feedback on RUO/IUO... Oct 12
Rosen Quoted on Generic Drug Guidelines 27 October 2011 –Bloomberg News Foley Partner David Rosen was quoted in an article that appeared in Bloomberg News on October 27, 2011 titled "FDA tightens standards to prove generics can be swapped."... Oct 27
Rosen Quoted in Law360 10 May 2013 –Law360 Partner David L. Rosen was quoted in a May 10, 2013 Law360 article titled, “Drug Cos. See Path to Legal Off-Label Marketing.” The piece discusses the drug industry’s... May 10
Rosen Quoted on Product Safety Evaluation 11 January 2012 –USA Today Foley Partner David Rosen discusses product safety evaluation following the Food and Drug Administration's (FDA) warning of fines and sanctions to Johnson &... Jan 11
Key on GlaxoSmithKline Petition 11 August 2008 –National Law Journal Foley attorney Sarah Key authored an article titled “Glaxo’s big, fat attack on dietary supplements” in the August 11, 2008 issue of the National Law Journal. The... Aug 11
Rosen Quoted on Johnson & Johnson 23 July 2010 –CNN Money Foley Partner David Rosen was quoted in an article that appeared in CNN Money on July 23, 2010 titled “Pepcid factory problems mirror Tylenol mess.” Rosen discusses... Jul 23
Rosen Quoted on Foreign Clinical Trials 24 June 2010 –FDA Week Foley Partner David Rosen was quoted in an article that appeared in FDA Week on June 24, 2010 titled “OIG, Stakeholders Urge FDA To Clamp Down On Foreign Clinical... Jun 24
Rosen Quoted on FDA Compliance Regulations 24 August 2010 –CNNMoney Foley Partner David Rosen was quoted in an article that appeared in CNNMoney on August 24, 2010 titled "Recall fallout: FDA puts execs on notice." Rosen discusses... Aug 24